A multi-center, open label, crossover designed prospective study evaluating the effects of lipid lowering treatment on steroid synthesis in patients with Type 2 diabetes (MODEST Study).

Kanat, M; Serin, E; Tunckale, A; Yildiz, O; Sahin, S; Bolayirli, M; Arinc, H; Dirican, A; Karagoz, Y; Altuntas, Y; Celebi, H; Oguz, A

Kanat, M; Serin, E; Tunckale, A; Yildiz, O; Sahin, S; Bolayirli, M; Arinc, H; Dirican, A; Karagoz, Y; Altuntas, Y; Celebi, H; Oguz, A.

Affiliation

Kanat M; Department of Internal Medicine, Izzet Baysal Medical School, Abant Izzet Baysal University, TR14280-Golkoy, Bolu, Turkey. mustafa.kanat@gmail.com

J Endocrinol Invest ; 32(10): 852-6, 2009 Nov.

Article de En | MEDLINE | ID: mdl-19783896

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrroles / Azétidines / Diabète de type 2 / Acides heptanoïques / Cholestérol LDL Type d'étude: Clinical_trials / Observational_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: J Endocrinol Invest Année: 2009 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google